Skip to main content

. 1968 Aug;31(4):326–329. doi: 10.1136/jnnp.31.4.326

The effect of neuroleptic drug treatment on plasma fibrinogen concentrations in schizophrenic states.

C J Brackenridge, I H Jones

PMCID: PMC496369 PMID: 5684392

326

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BERGEN J. R., KOELLA W. P., FREEMAN H., HOAGLAND H. A human plasma factor inducing behavioral and electro-physiological changes in animals. II. Changes induced in animals. Ann N Y Acad Sci. 1962 Jan 13;96:469–476. doi: 10.1111/j.1749-6632.1962.tb50140.x. [DOI] [PubMed] [Google Scholar]
BRACKENRIDGE C. J. The interaction of plasma fibrinogen with anticoagulants in vitro. Clin Chim Acta. 1960 Jul;5:552–558. doi: 10.1016/0009-8981(60)90067-x. [DOI] [PubMed] [Google Scholar]
CARVER M. J. Long-term study of chlorpromazine and meprobamate on serum protein profile. J Nerv Ment Dis. 1962 Aug;135:126–130. doi: 10.1097/00005053-196208000-00005. [DOI] [PubMed] [Google Scholar]
Cameron I. A., Dawson J. The relationship between dextran precipitable fibrinogen and 170H corticosteroid levels in psychotic subjects. J Psychosom Res. 1967 Aug;11(2):157–162. doi: 10.1016/0022-3999(67)90001-3. [DOI] [PubMed] [Google Scholar]
ELLIOTT F. A., BUCKELL M. Fibrinogen changes in relation to cerebrovascular accidents. Neurology. 1961 Feb;11:120–124. doi: 10.1212/wnl.11.2.120. [DOI] [PubMed] [Google Scholar]
FESSEL W. J. Blood proteins in functional psychoses. A review of the literature and unifying hypothesis. Arch Gen Psychiatry. 1962 Feb;6:132–148. doi: 10.1001/archpsyc.1962.01710200024004. [DOI] [PubMed] [Google Scholar]
Heath R. G., Krupp I. M., Byers L. W., Liljekvist J. I. Schizophrenia as an immunologic disorder. II. Effects of serum protein fractions on brain function. Arch Gen Psychiatry. 1967 Jan;16(1):10–23. doi: 10.1001/archpsyc.1967.01730190012002. [DOI] [PubMed] [Google Scholar]
Heath R. G., Krupp I. M. Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques. Arch Gen Psychiatry. 1967 Jan;16(1):1–9. doi: 10.1001/archpsyc.1967.01730190003001. [DOI] [PubMed] [Google Scholar]
STIRLAND R. M. A rapid method of estimating fibrinogen. Lancet. 1956 May 12;270(6924):672–672. doi: 10.1016/s0140-6736(56)90699-7. [DOI] [PubMed] [Google Scholar]
Seal U. S., Swaim W. R., Eist H. Hyperfibrinogenemia in schizophrenia. Clin Chem. 1967 Feb;13(2):160–162. [PubMed] [Google Scholar]
TRIGOS G., MCCULLOUGH W. The protein profile in chlorpromazine therapy. Dis Nerv Syst. 1955 Oct;16(10):309–311. [PubMed] [Google Scholar]
YUWILER A., JENKINS I. M., DUKAY A. Serum oxidase tests and schizophrenia. Arch Gen Psychiatry. 1961 Apr;4:395–403. doi: 10.1001/archpsyc.1961.01710100075009. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES